Shanghai ZJ Bio-Tech Co. Ltd. A - Asset Resilience Ratio
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 10.88% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. See 688317 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688317 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥403.46 Million | 10.88% |
| Total Liquid Assets | CN¥403.46 Million | 10.88% |
Asset Resilience Insights
- Moderate Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A has 10.88% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM |
Medical Devices | 46.67% |
|
Allmed Solutions Ltd
TA:ALMD |
Medical Devices | 80.03% |
|
Universal Biosensors Inc
AU:UBI |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2025)
The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.24% | CN¥347.89 Million ≈ $50.91 Million |
CN¥3.76 Billion ≈ $550.76 Million |
+6.60pp |
| 2014-12-31 | 2.64% | CN¥5.28 Million ≈ $772.52K |
CN¥199.63 Million ≈ $29.21 Million |
-- |
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.